Finzati - Logo
ADCT logo

ADC Therapeutics S.A.

ADCTBiotechnology
$1.36
+0.04 (+3.03%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$133.55M
Growth
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 9.7%Healthy liquidity · 4.37Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:22 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$1.36
Change3.03%
Market Cap$133.55M
52W Range0.78 - 4.98
Beta1.84
Gross Margin90.57%
Oper. Margin-133.21%
Profit Margin-175.31%
Debt/Eq-2.36
Current Ratio4.37
Quick Ratio4.31
Target$3.50

Investment DNA

How strong this company looks for long-term investors

48
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
94/100
Price Attractiveness
Cheap or expensive today
57/100
Why this score
Positive revenue growth · 9.7%Healthy liquidity · 4.37Weak profitability

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-14
Low
$2.00
Mean
$3.50
Median
$3.50
High
$5.00

Company Overview

IPO: 5/18/2020
Industry: Biotechnology
P/B i: -2.41
Debt / Equity i: -2.36
Operating Margin: -133.21%
Net Margin: -175.31%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: -2.36
Current Ratio: 4.37
Quick Ratio: 4.31
Status: Good

Insider Transactions

Recent executive and insider activity

5 high-volume insider sells detected
MALLIK AMEET
Transaction: 06/30/2026
BUY
Change
+675,000
Price
Not reported
Filing
07/02/2026
Type
BUY
Carmona Jose
Transaction: 06/30/2026
BUY
Change
+203,700
Price
Not reported
Filing
07/02/2026
Type
BUY
GRAHAM PETER J
Transaction: 06/30/2026
BUY
Change
+221,100
Price
Not reported
Filing
07/02/2026
Type
BUY